A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan

A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan

The incidence of multiple myeloma in Asia has risen in the past 30 years. Lenalidomide, an IMiD immunomodulatory agent, has improved the overall survival in patients with relapsed/refractory multiple myeloma (RRMM) when used with dexamethasone versus dexamethasone alone. This observational registry...

Full description

Bibliographic Details
Main Authors: Shang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, Tsai-Yun Chen, Woei-Yau Kao, Chih-Cheng Chen, Ming-Chung Wang, Hsuan-Yu Lin, Sheng-Fung Lin, Tseng-Hsi Lin, Ye Hua, Marie Puccio-Pick, Dena DeMarco, Christian Jacques, Po Dunn
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Journal of the Formosan Medical Association
Subjects:
dexamethasone
lenalidomide
multiple myeloma
registry
Online Access:http://www.sciencedirect.com/science/article/pii/S092966461630393X

Internet

http://www.sciencedirect.com/science/article/pii/S092966461630393X

Similar Items